9-[4-[2-cyano-5-[2-[3-ethenyl-2-[(Z)-prop-1-enyl]indol-1-yl]phenyl]phenyl]phenyl]carbazole-2-carbonitrile
C45H30N4 — CID 155085788
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-[4-[2-cyano-5-[2-[3-ethenyl-2-[(Z)-prop-1-enyl]indol-1-yl]phenyl]phenyl]phenyl]carbazole-2-carbonitrile
9-[4-[2-cyano-5-[2-[3-ethenyl-2-[(Z)-prop-1-enyl]indol-1-yl]phenyl]phenyl]phenyl]carbazole-2-carbonitrile (PubChem CID 155085788) has the molecular formula C45H30N4 and a molecular weight of 626.76 g/mol. Its IUPAC name is 9-[4-[2-cyano-5-[2-[3-ethenyl-2-[(Z)-prop-1-enyl]indol-1-yl]phenyl]phenyl]phenyl]carbazole-2-carbonitrile.
Molecular Properties
| Compound Name | 9-[4-[2-cyano-5-[2-[3-ethenyl-2-[(Z)-prop-1-enyl]indol-1-yl]phenyl]phenyl]phenyl]carbazole-2-carbonitrile |
|---|---|
| PubChem CID | 155085788 |
| Molecular Formula | C45H30N4 |
| Molecular Weight | 626.76 g/mol |
| Exact Mass | 626.25 |
| IUPAC Name | 9-[4-[2-cyano-5-[2-[3-ethenyl-2-[(Z)-prop-1-enyl]indol-1-yl]phenyl]phenyl]phenyl]carbazole-2-carbonitrile |
| SMILES | C=Cc1c(/C=C\C)n(-c2ccccc2-c2ccc(C#N)c(-c3ccc(-n4c5ccccc5c5ccc(C#N)cc54)cc3)c2)c2ccccc12 |
| InChI | InChI=1S/C45H30N4/c1-3-11-41-35(4-2)37-13-6-10-17-44(37)49(41)42-15-8-5-12-36(42)32-19-20-33(29-47)40(27-32)31-21-23-34(24-22-31)48-43-16-9-7-14-38(43)39-25-18-30(28-46)26-45(39)48/h3-27H,2H2,1H3/b11-3- |
| InChIKey | UBFOWYVTVIFPNT-JYOAFUTRSA-N |
| XLogP | 11.48 |
| TPSA | 57.44 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 49 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 626.76 |
| LogP ≤ 5 | 11.48 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155085788 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.